About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clinical Trials in New York | 22,668 Studies Near You | Clareo Health

Clinical Trials LocationsNew York

Clinical Trials in New York

Discover 22,668 clinical trials near New York, New York. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Filters

Sort by

Status

Recruiting(Enrolling)

Not yet recruiting

Active, not recruiting

Enrolling by invitation(Enrolling)

Completed

Terminated

Phase

Early Phase 1

Phase 1

Phase 1/Phase 2

Phase 2

Phase 2/Phase 3

Phase 3

Phase 4

Not Applicable

Eligibility

Accepts healthy volunteers

Showing 22281-22300 of 22,668 trials

COMPLETEDPhase 3< 1 mile

A Study to Assess the Safety and Effectiveness of Tacrolimus Cream in the Treatment of Psoriasis

NCT00293930

A study to assess the safety and effectiveness of tacrolimus cream in the treatment of psoriasis

Astellas Pharma Inc645 participants

Hot Springs, Arkansas, United States • San Diego, California, United States • San Francisco, California, United States +29 more locations

COMPLETEDPhase 3< 1 mile

A Study to Assess the Safety and Effectiveness of Tacrolimus Cream in the Treatment of Psoriasis

NCT00293891

A study to assess the safety and effectiveness of tacrolimus cream in the treatment of psoriasis.

Astellas Pharma Inc658 participants

Birmingham, Alabama, United States • Little Rock, Arkansas, United States • San Diego, California, United States +30 more locations

Find Trials by Condition in New York

Breast Cancerin New York Lung Cancerin New York Prostate Cancerin New York Colorectal Cancerin New York Melanomain New York Leukemiain New York Lymphomain New York Pancreatic Cancerin New York Ovarian Cancerin New York Brain Cancerin New York Diabetes

Data from ClinicalTrials.govTerms

COMPLETEDPhase 3< 1 mile

Efficacy, Tolerability and Safety of Dexmethylphenidate HCl Extended-Release Capsules in Children With Attention-Deficit/Hyperactivity Disorder

NCT00301236

The purpose of this study is to determine which dosages of dexmethylphenidate HCl extended-release capsules may represent effective treatment for ADHD in children 6-12 years of age.

Novartis252 participantsStarted Feb 2006

Mesa, Arizona, United States • Little Rock, Arkansas, United States • Los Angeles, California, United States +22 more locations

COMPLETEDPhase 3< 1 mile

Minocycline to Treat Amyotrophic Lateral Sclerosis

NCT00047723

The purpose of this trial is to test the safety, tolerability, and effectiveness of minocycline compared to placebo in patients with amyotrophic lateral sclerosis (ALS).

Amyotrophic Lateral Sclerosis

National Institute of Neurological Disorders and Stroke (NINDS)400 participantsStarted Jan 2003

Scottsdale, Arizona, United States • Irvine, California, United States • Los Angeles, California, United States +27 more locations

TERMINATEDPhase 3< 1 mile

Clinical Trial for Ovarian Cancer (OvaRex®)

NCT00050375

This study will compare the time to disease relapse between OvaRex® MAb-B43.13-treated patients and placebo-treated patients. This study will also compare assessments of survival, quality of life, immune response and safety between active and placebo groups.

Unither Pharmaceuticals354 participantsStarted Dec 2002

Huntsville, Alabama, United States • Phoenix, Arizona, United States • Little Rock, Arkansas, United States +59 more locations

TERMINATEDPhase 28.9 miles

Study Evaluating GAP-486 on Heart Rhythm in Patients With Coronary Artery Disease

NCT00137332

The purpose of this study is to learn the effects of a test drug on heart rhythms, which may become life-threatening if left untreated, and to provide data to see if the drug is well tolerated and safe.

Wyeth is now a wholly owned subsidiary of Pfizer90 participantsStarted Nov 2005

Sacramento, California, United States • San Francisco, California, United States • Washington D.C., District of Columbia, United States +30 more locations

UNKNOWNPhase 213 miles

Randomized Trial of ATN-224 and Temozolomide in Advanced Melanoma

NCT00383851

This is a multicenter, randomized, phase II study to evaluate the safety and efficacy of oral ATN-224 plus temozolomide in patients with advanced melanoma. Patients will be randomized (1:1) between temozolomide and ATN-224 and temozolomide followed by ATN-224. Patients assigned to the sequential treatment group will receive temozolomide until progression of disease is documented and then receive ATN-224 as a single agent until documentation of progression of disease using the last tumor assessment on temozolomide therapy as the baseline assessment.

Attenuon60 participantsStarted Sep 2006

Tucson, Arizona, United States • Encinitas, California, United States • Orange, California, United States +14 more locations

COMPLETEDPhase 116 miles

Study To Evaluate The Pharmacokinetic Interaction Between PLA-695 And Methotrexate In Adults With Rheumatoid Arthritis

NCT00440492

The purpose of this study is to determine if PLA-695 changes the blood concentrations of methotrexate when administered together.

Arthritis, Rheumatoid

Wyeth is now a wholly owned subsidiary of PfizerStarted Dec 2006

Los Angeles, California, United States • Palo Alto, California, United States • Lake Success, New York, United States +6 more locations

COMPLETEDPhase 316 miles

Study of Milnacipran for the Treatment of Fibromyalgia

NCT00098124

Antidepressants of all varieties represent a common form of therapy for many chronic states including fibromyalgia. The majority of antidepressants increase the levels of serotonin or norepinephrine in the central nervous system. Milnacipran is a dual norepinephrine and serotonin reuptake inhibitor and may be effective in the treatment of fibromyalgia.

Forest Laboratories1,200 participantsStarted Nov 2004

Birmingham, Alabama, United States • Mobile, Alabama, United States • Montgomery, Alabama, United States +77 more locations

COMPLETEDPhase 420 miles

Study of the Effects of Current Drug Treatments on Levels of Certain Brain Chemicals in Alzheimer's Disease

NCT00104442

Alzheimer's disease is a medical illness that damages the brain and causes problems with memory, mood and behavior. A substance called acetylcholine (ACh), which is naturally produced in the body, plays an important role in the normal functioning of the brain. In subjects with Alzheimer's disease, the level of ACh is greatly reduced. Currently, there are three commonly prescribed drugs used for treating the symptoms of Alzheimer's disease by helping to maintain the level of ACh in the brain. This study will evaluate how much each of these drugs changes the levels of certain brain chemicals that are known to, or may play an important role in, Alzheimer's disease and its symptoms.

Alzheimer's Disease

Novartis80 participantsStarted Oct 2003

East Hanover, New Jersey, United States

COMPLETEDPhase 335 miles

Study Evaluating the Effects of DVS SR and Paroxetine on the Pharmacokinetics of Desipramine in Healthy Subjects

NCT00329147

The purpose of this study is to evaluate the effects of multiple doses of DVS SR and paroxetine on the pharmacokinetics of a single dose of desipramine in healthy subjects.

Wyeth is now a wholly owned subsidiary of Pfizer20 participantsStarted May 2006

Neptune City, New Jersey, United States

COMPLETEDPhase 443 miles

Comparison of Diagnostic Rest/Stress SPECT Results for Patients With Myocardial Ischemia and Infarction Using Myoview in Both Single and Dual Isotope Acquisition Approaches

NCT00381316

The study is designed to determine whether a dual isotope protocol is equivalent to a single isotope in the diagnosis of myocardial ischemia and infarction using MYOVIEW SPECT imaging.

Coronary Artery Disease

GE Healthcare291 participantsStarted Jul 2006

Princeton, New Jersey, United States

COMPLETEDPhase 248 miles

Study Evaluating the Safety and Efficacy of ERB-041 on Reduction of Symptoms Associated With Endometriosis in Reproductive-Aged Women

NCT00318500

The purpose of the study is to evaluate the efficacy and safety of two doses of ERB-041 (75 mg and 150 mg) relative to placebo on the relief of endometriosis-related symptoms (dysmenorrhea, pelvic pain, and deep dyspareunia) in reproductive aged women.

DysmenorrheaDyspareuniaEndometriosis+1 more

Wyeth is now a wholly owned subsidiary of Pfizer150 participantsStarted May 2006

Montgomery, Alabama, United States • Chandler, Arizona, United States • Phoenix, Arizona, United States +67 more locations

TERMINATEDPhase 365 miles

A Clinical Trial Comparing Torcetrapib/Atorvastatin to Ezetimibe/Simvastatin In Subjects With A Cholesterol Disorder.

NCT00267267

The Torcetrapib project was terminated on December 2, 2006 due to safety findings. Cholesterol levels will be measured over six weeks in subjects being treated with two different kinds of combination cholesterol medications to see how the different treatments compare to one another.

HyperlipidemiaDyslipidemia

Pfizer1,784 participantsStarted Jan 2006

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Chandler, Arizona, United States +120 more locations

COMPLETEDPhase 2/373 miles

Study Evaluating DVS SR in Patients With Fibromyalgia Syndrome

NCT00424892

The primary objective is to evaluate the long-term safety of desvenlafaxine succinate sustained-release (DVS SR) during open-label treatment in adult outpatients with fibromyalgia syndrome.

Wyeth is now a wholly owned subsidiary of Pfizer600 participants

Huntsville, Alabama, United States • Mobile, Alabama, United States • Phoenix, Arizona, United States +56 more locations

TERMINATEDPhase 2/373 miles

Study Evaluating the Efficacy of DVS-233 in Fibromyalgia

NCT00301431

The purpose of this study is to determine if DVS-233 is safe and effective in the treatment of pain and other symptoms of fibromyalgia syndrome.

Wyeth is now a wholly owned subsidiary of Pfizer1,050 participantsStarted Aug 2006

Huntsville, Alabama, United States • Mobile, Alabama, United States • Phoenix, Arizona, United States +56 more locations

COMPLETEDPhase 2/3183 miles

Gabapentin in Fibromyalgia Trial (GIFT)

NCT00057278

This study will assess the safety and effectiveness of the drug gabapentin in reducing pain associated with primary fibromyalgia.

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)150 participantsStarted Mar 2003

Belmont, Massachusetts, United States • Newton, Massachusetts, United States • Cincinnati, Ohio, United States

COMPLETEDPhase 3274 miles

Effects in The ApoB/ApoA-I Ratio Using Rosuvastatin and Atorvastatin in Patients With Acute Coronary Syndrome

NCT00296387

The purpose of this study is to see if rosuvastatin compared to Atorvastatin is effective in treating ACS by decreasing the ApoB/ApoA-1 ratio and if starting statin within 24 h following the onset of the first symptoms is beneficial compared to placebo.

Acute Coronary Syndrome

AstraZeneca1,160 participantsStarted Jan 2006

Aalst, Belgium • Bonheiden, Belgium • Bouge, Belgium +99 more locations

COMPLETEDPhase 3274 miles

The Study of Drotrecogin Alfa (Activated) in Adult Patients With Severe Sepsis at a Low Risk of Death

NCT00568737

Adult Patients with Severe Sepsis

Eli Lilly and Company2,640 participantsStarted Nov 2002

Haedi, Buenos Aires, Argentina • Monte Grande, Buenos Aires, Argentina • Rosario - Santa Fe, Buenos Aires, Argentina +67 more locations

COMPLETEDPhase 22133 miles

A Study of Pemetrexed Plus Doxorubicin Given to Patients With Advanced Breast Cancer

NCT00102219

This is a non-randomized Phase 2 study testing pemetrexed and doxorubicin in combination for locally advanced or metastatic breast cancer. Both pemetrexed and doxorubicin have been combined with other drugs, but they have not yet been combined with each other. It is expected that the patient will benefit from the different mechanisms of action of the two drugs. However, there is no guarantee that the patient will benefit from this treatment.

Eli Lilly and Company77 participantsStarted Oct 2004

Belo Horizonte, BH, Brazil • São Paulo, São Paulo, Brazil • Rio de Janeiro, Brazil +9 more locations

PreviousPage 1115 of 1134Next

in New York

Heart Diseasein New York